Pre-formulation studies Flashcards
what is pre-formulation testing
- in drug discovery
- to understand physical, chemical, analytical, and pharmaceutical properties of molecule
- possible ideas for modification of molecule for better performance
- studies on the quality of raw materials (APIs and excipients); ensuring quality, meet specifications
- identify critical material attributes (CMAs) that could impact CQA of a product
why is pre-formulation testing important (singificance)
studies on API
- whether formulations or manufacturing methods can make a viable product
- provide clues on how to achieve desired finished pdt
- confirm stability and bioavailability (minimise risk of formulation/pdt failure)
- more likely to form a better quality product (even though high cost to do such studies)
whats the purpose of conducting preformulation tests
- [primary characterisation] of API/ excipients for physical and chemical properties
- ensure quality of raw materials, confirm the suppliers info (reliable)
- provide impt data that may be impt for subsequent events
what are the benefits for conducting preformulation studies
- set specifications for API (ensuring consistency of batches)
- ensure optimal pdt formed before costly bioavailable and bioequivalence studies are done
- prevent failure during long-term stability (whether ingredients are compatible, stability of API)
- minimise need for in vivo bioavailable/bioequivalence studies
- -> BCS done in vitro
what are the physical measurements available for pre-formulation studies
- Particle shape
- surface area (BET etc)
- density
- solubility
- solid-moisture interactions (DVS)
the various densities for characterising granulations
true (particle, real, absolute, skeletal) density; weight/ true volume
where true volume = vol occupied w/o voids
apparent density;
- bulk
- tapped
- envelope (bulk w/o inter-agglomerate void; means it measure the voids present between particles as well)
BCS determines
- solubility of active in aq media of various pH
- ability of API to cross gut wall (GI permeability)
classes in BCS; and which have a biowaiver (means which classes don’t need to in vivo)
solubility, permeability
I: high, high
II: low, high (focus on in vitro dissolution)
III: high, low (optimise absorption/route)
IV: low, low (maybe molecule modification
class I and III are BCS-based biowaiver
why are stability studies important
monitors ageing non-chemical characteristics:
(1) particle size (large particles will grow, small particles shrink/dissolve in suspension)
(2) polymorphic form (solubility changes when amorphous becomes crystalline)
(3) dissolution rate (esp w polymorphic transformation)
(4) preservative efficacy, sterility; incompatibility
bioavailability of drug is affected by?
disintegration and dissolution in GITransit
absorption in GIT (systemic absorption) –> bloodstream (affected by first-pass clearance)
what to take note whe forming a dosage form?
(1) manufacturability
- scalable
- reproducible
- cost-effective
(2) stability
- during manufacture
- shelf-life (ideal 2 yrs)
- in GIT
(3) bioavailability
- for therapeutic action
- convenience and compliance
what do pre-formulation test focus on?
the physical aspect of raw material; greater influence on the manufacturing process
2 shape factors that can determine flowability in the particle shape method
sphericity = (4 x pi x area)/(perimeter)^2
aspect ratio = length / breadth
how is surface area measured
using gas permeability or adsorption
e.g. BET - determines specific surface area
e. g. estimation from size
disadv: shape factor not taken into account, usually underestimation
how does BET works?
added N2 to a solid at cryogenic temperatures
gas will be adsorbed via weak molecular attractive forces
by measuring pressure, we can find volume of gas adsorbed
p x V = constant –> therefore, p is inversely proportional to V
we know cross-sectional area of each adsorbed gas molecule –> allow us to find s.a. and pore size distribution